Bank Of America Corp Agenus Inc Transaction History

Bank Of America Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$0.53 - $0.93 $542 - $952	1,024 Added 0.08%	1,338,647 $776,000
Q4 2023 Feb 14, 2024	BUY	$0.63 - $1.14 $273,600 - $495,087	434,287 Added 48.08%	1,337,623 $1.11 Million
Q2 2023 Aug 14, 2023	SELL	$1.31 - $2.04 $9.25 Million - $14.4 Million	-7,061,941 Reduced 88.66%	903,336 $1.45 Million
Q1 2023 May 12, 2023	BUY	$1.45 - $2.95 $9.77 Million - $19.9 Million	6,736,276 Added 548.11%	7,965,277 $12.1 Million
Q4 2022 Feb 10, 2023	SELL	$2.02 - $3.25 $930,100 - $1.5 Million	-460,446 Reduced 27.25%	1,229,001 $2.95 Million
Q3 2022 Nov 14, 2022	BUY	$1.96 - $3.14 $3.05 Million - $4.89 Million	1,557,773 Added 1183.05%	1,689,447 $3.46 Million
Q2 2022 Aug 12, 2022	BUY	$1.3 - $2.64 $76,564 - $155,485	58,896 Added 80.93%	131,674 $255,000
Q1 2022 May 16, 2022	SELL	$2.35 - $3.47 $151,967 - $224,394	-64,667 Reduced 47.05%	72,778 $178,000
Q4 2021 Feb 08, 2022	BUY	$2.92 - $5.74 $37,162 - $73,052	12,727 Added 10.2%	137,445 $443,000
Q3 2021 Nov 15, 2021	SELL	$4.98 - $6.63 $572,336 - $761,966	-114,927 Reduced 47.96%	124,718 $654,000
Q2 2021 Sep 13, 2021	BUY	$2.56 - $5.49 $613,491 - $1.32 Million	239,645 New	239,645 $1.32 Million

2.03M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.